Compare, Analyse Pfizer with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ACTAVIS (US) - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ACTAVIS
EQUITY SHARE DATA
    PFIZER
Mar-18
ACTAVIS
Dec-18
PFIZER/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs2,36513,746-   
Low Rs1,6259,221-   
Sales per share (Unadj.) Rs430.33,371.9-  
Earnings per share (Unadj.) Rs78.7-1,086.1-  
Cash flow per share (Unadj.) Rs93.2355.3-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.513,907.7-  
Shares outstanding (eoy) m45.75332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.63.4 136.1%   
Avg P/E ratio x25.3-10.6 -239.7%  
P/CF ratio (eoy) x21.432.3 66.2%  
Price / Book Value ratio x3.40.8 412.0%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2713,819,451 2.4%   
No. of employees `0002.616.9 15.6%   
Total wages/salary Rs m3,1430-   
Avg. sales/employee Rs Th7,484.866,361.4 11.3%   
Avg. wages/employee Rs Th1,195.00-   
Avg. net profit/employee Rs Th1,369.1-21,375.1 -6.4%   
INCOME DATA
Net Sales Rs m19,6851,121,508 1.8%  
Other income Rs m1,14321,447 5.3%   
Total revenues Rs m20,8281,142,955 1.8%   
Gross profit Rs m5,00329,389 17.0%  
Depreciation Rs m663479,421 0.1%   
Interest Rs m464,717 0.0%   
Profit before tax Rs m5,479-493,302 -1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,812 0.0%   
Tax Rs m1,878-6,252 -30.0%   
Profit after tax Rs m3,601-361,238 -1.0%  
Gross profit margin %25.42.6 969.8%  
Effective tax rate %34.31.3 2,705.2%   
Net profit margin %18.3-32.2 -56.8%  
BALANCE SHEET DATA
Current assets Rs m24,167459,984 5.3%   
Current liabilities Rs m9,544406,917 2.3%   
Net working cap to sales %74.34.7 1,569.9%  
Current ratio x2.51.1 224.0%  
Inventory Days Days5520 281.3%  
Debtors Days Days2966 43.3%  
Net fixed assets Rs m9,514126,948 7.5%   
Share capital Rs m4580-   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,8324,625,699 0.6%   
Long term debt Rs m251,628,876 0.0%   
Total assets Rs m36,9007,231,020 0.5%  
Interest coverage x1,305.5-6.6 -19,714.1%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.50.2 344.0%   
Return on assets %9.8-4.1 -238.2%  
Return on equity %13.4-7.8 -171.8%  
Return on capital %20.4-4.8 -421.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
CASH FLOW
From Operations Rs m3,318400,673 0.8%  
From Investments Rs m-2,383220,117 -1.1%  
From Financial Activity Rs m-1,104-687,674 0.2%  
Net Cashflow Rs m-169-66,550 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare PFIZER With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PFIZER With: AJANTA PHARMA  SUVEN LIFESCIENCES  ORCHID PHARMA LTD  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Sensex Ends 87 Points Higher; Telecom and Auto Stocks Witness Buying(Closing)

Indian share markets ended their trading session marginally higher. On the sectoral front, gains were seen in the telecom sector and auto sector.

Related Views On News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound? (Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again (The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Oct 14, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS